Αρχική World News Surgical Technique Helps Keep Breast Cancer Patients from Going Under the Knife...

Surgical Technique Helps Keep Breast Cancer Patients from Going Under the Knife Again

Breast cancer surgery is something no one wants to have to do, but it’s made much worse for patients who have to go under the knife again because surgeons weren’t able to get all of the cancer the first time. This means more stress, more recovery time, more pain, a higher likelihood for infection, and a higher cost. And, of course, the longer this process takes, the longer it takes to get the patient into the next phase of treatment and the more time the cancer has to grow and metastasize.The reason this problem occurs so frequently is that cancerous tumors, particularly small ones, are difficult to differentiate from healthy tissue. Surgeons rely on the appearance of the tissue and their own best judgement to determine whether they’ve removed everything they needed to remove, and they won’t know whether they were right or not until the pathology report comes back, usually several days after the surgery. This guesswork often results in surgeons getting it wrong, through no real fault of their own.Photo: Adobe Stock/Andrey
Now, however, surgeons are beginning to use a new technique, called “resection of cavity shave margins,” to help get all the cancer out the first time so that patients are less likely to have to go through repeat operations. The technique is essentially a partial mastectomy, a removal of the tumor along with a larger-than-normal area of the margins around the tumor. By removing extra healthy tissue along with the tumor, surgeons have a better chance of getting the job done right the first time.“Historically, 20 to 40 percent of the time we would end up with cancer cells at the edge and we would need to tell our patients we’d have to take them back for a second surgery,” says Dr. Anees Chagpar, a breast cancer surgeon, a professor at Yale School of Medicine, and the study’s senior author. “This is not a good situation for the surgeon, the patient, or the health system. We wondered, simply by taking a little bit more tissue, could we reduce the positive [cancerous] margin?”Photo: Adobe Stock/focusandblur
Chagpar’s study followed 235 Yale breast cancer patients who were undergoing a mastectomy surgery and determined that taking extra tissue from the margins around the breast tumor reduced the need for additional surgeries by half. That’s a lot of women that won’t need to go under the knife again to remove their cancer!Happily, researchers also found that taking out extra tissue did not negatively impact patients’ healing time, create problems with wound healing, or create cosmetic issues, at least in the short-term. Following the study, Chagpar conducted the same research in smaller community hospitals that had no fellowships in nine geographical locations. The findings showed that the results were applicable in these places as well.In the most recent study, Chagpar separated patients randomly into a “shave” and “no shave” categories. The patients who underwent the traditional “no shave” procedure still had cancer left over in the marginal tissue 36 percent of the time, and they required an additional surgery 23.5 percent of the time. Those who had extra tissue shaved off the margins only had leftover cancer in their bodies 9.7 percent of the time and only underwent extra surgeries 8.7 percent of the time. The difference, Chagpar says, is highly statistically significant.
Photo: Adobe Stock/Mladen“The potential downside is the higher volume of tissue being removed,” says Dr. Niamey Wilson, a breast cancer surgeon and director of research and quality for breast surgery at Hartford HealthCare. “Most women would happily exchange that for not having to return to the operating room a second time.”Sadly, many surgeons do not perform this cavity shave technique yet. We hope, however, that with the research on the subject bringing to light the benefits of the procedure, more surgeons will take notice and begin practicing it in the near future.
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...